Shingen Misaka

1.2k total citations
47 papers, 955 citations indexed

About

Shingen Misaka is a scholar working on Pathology and Forensic Medicine, Pharmacology and Oncology. According to data from OpenAlex, Shingen Misaka has authored 47 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 12 papers in Pharmacology and 11 papers in Oncology. Recurrent topics in Shingen Misaka's work include Tea Polyphenols and Effects (15 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Drug Transport and Resistance Mechanisms (10 papers). Shingen Misaka is often cited by papers focused on Tea Polyphenols and Effects (15 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Drug Transport and Resistance Mechanisms (10 papers). Shingen Misaka collaborates with scholars based in Japan, Germany and Italy. Shingen Misaka's co-authors include Shizuo Yamada, Satomi Onoue, Martin F. Fromm, Fabian Müller, Junko Kimura, Hiroshi Watanabe, José Pablo Werba, Hartmut Glaeser, Hideyuki Sato and Jörg König and has published in prestigious journals such as PLoS ONE, International Journal of Pharmaceutics and Clinical Pharmacology & Therapeutics.

In The Last Decade

Shingen Misaka

44 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingen Misaka Japan 19 261 228 201 148 124 47 955
Hatem A. Salem Egypt 22 158 0.6× 268 1.2× 187 0.9× 443 3.0× 151 1.2× 50 1.3k
Tomomi Sugiyama Japan 19 339 1.3× 139 0.6× 372 1.9× 347 2.3× 74 0.6× 42 1.2k
Emad H. M. Hassanein Egypt 26 416 1.6× 289 1.3× 107 0.5× 566 3.8× 147 1.2× 71 1.6k
Salma Malik India 21 306 1.2× 168 0.7× 77 0.4× 381 2.6× 93 0.8× 43 1.4k
Amr A. Fouad Saudi Arabia 25 265 1.0× 206 0.9× 83 0.4× 415 2.8× 199 1.6× 52 1.5k
Sumit Sharma India 17 140 0.5× 220 1.0× 110 0.5× 327 2.2× 95 0.8× 22 964
Mona F. Schaalan Egypt 22 143 0.5× 100 0.4× 149 0.7× 443 3.0× 111 0.9× 65 1.4k
Sana Nafees India 23 415 1.6× 466 2.0× 186 0.9× 534 3.6× 188 1.5× 47 1.7k
Eman Said Egypt 23 159 0.6× 199 0.9× 324 1.6× 562 3.8× 188 1.5× 71 1.4k
Wani Arjumand India 14 219 0.8× 189 0.8× 126 0.6× 376 2.5× 62 0.5× 21 910

Countries citing papers authored by Shingen Misaka

Since Specialization
Citations

This map shows the geographic impact of Shingen Misaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingen Misaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingen Misaka more than expected).

Fields of papers citing papers by Shingen Misaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingen Misaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingen Misaka. The network helps show where Shingen Misaka may publish in the future.

Co-authorship network of co-authors of Shingen Misaka

This figure shows the co-authorship network connecting the top 25 collaborators of Shingen Misaka. A scholar is included among the top collaborators of Shingen Misaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingen Misaka. Shingen Misaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misaka, Shingen, et al.. (2024). Comparative analysis of functional components in Sakekasu (Sake lees). Functional Foods in Health and Disease. 14(1). 74–74. 3 indexed citations
2.
Misaka, Shingen, Akiko Satô, Takahiro Suto, et al.. (2023). Effect of lemborexant on pharmacokinetics of clozapine: A potential drug–drug interaction mediated by time‐dependent inhibition of CYP3A4. British Journal of Clinical Pharmacology. 90(1). 354–359. 5 indexed citations
3.
Ghosh, Antara, Sujan Banik, Kohei Yamada, et al.. (2023). Stabilized Astaxanthin Nanoparticles Developed Using Flash Nanoprecipitation to Improve Oral Bioavailability and Hepatoprotective Effects. Pharmaceutics. 15(11). 2562–2562. 7 indexed citations
4.
Ono, Yuko, Masafumi Saito, K. Sakamoto, et al.. (2022). C188-9, a specific inhibitor of STAT3 signaling, prevents thermal burn-induced skeletal muscle wasting in mice. Frontiers in Pharmacology. 13. 1031906–1031906. 13 indexed citations
5.
Misaka, Shingen, Hideyuki Sato, Tomoyuki Ono, et al.. (2018). Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers. European Journal of Clinical Pharmacology. 74(5). 601–609. 12 indexed citations
6.
Misaka, Shingen, et al.. (2018). Memantine has no effect on KATP channels in pancreatic β cells. BMC Research Notes. 11(1). 614–614. 11 indexed citations
7.
Misaka, Shingen, Junichi Yatabe, Fabian Müller, et al.. (2014). Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects. Clinical Pharmacology & Therapeutics. 95(4). 432–438. 107 indexed citations
8.
Misaka, Shingen, Midori Yatabe, Tomoyuki Ono, et al.. (2013). Pharmacokinetic and Pharmacodynamic Interaction of Nadolol With Itraconazole, Rifampicin and Grapefruit Juice in Healthy Volunteers. The Journal of Clinical Pharmacology. 53(7). 738–745. 25 indexed citations
9.
Misaka, Shingen, et al.. (2013). Effects of green tea extract and (−)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats. Phytomedicine. 20(14). 1247–1250. 27 indexed citations
10.
Ogata, Hiroshi, Midori Yatabe, Shingen Misaka, et al.. (2013). EFFECT OF ORAL L-ARGININE ADMINISTRATION ON EXHALED NITRIC OXIDE (NO) CONCENTRATION IN HEALTHY VOLUNTEERS. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 59(1). 43–48.
11.
Misaka, Shingen, et al.. (2013). Effects of Itraconazole, Dexamethasone and Naringin on the Pharmacokinetics of Nadolol in Rats. Drug Metabolism and Pharmacokinetics. 28(4). 356–361. 11 indexed citations
12.
Onoue, Satomi, Yosuke Aoki, Takuya Matsui, et al.. (2011). Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R15, 20, 21, L17, A24,25, des-N28]-VIP-GRR) in experimental asthma/COPD model rats. International Journal of Pharmaceutics. 410(1-2). 54–60. 13 indexed citations
13.
14.
Onoue, Satomi, Shingen Misaka, Yosuke Aoki, et al.. (2010). Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. European Journal of Pharmaceutical Sciences. 41(3-4). 508–514. 12 indexed citations
15.
Misaka, Shingen, Hideyuki Sato, Yosuke Aoki, et al.. (2010). Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis. Peptides. 32(2). 401–407. 10 indexed citations
16.
Onoue, Satomi, Shingen Misaka, Yuki Ohmori, et al.. (2009). Physicochemical and pharmacological characterization of novel vasoactive intestinal peptide derivatives with improved stability. European Journal of Pharmaceutics and Biopharmaceutics. 73(1). 95–101. 9 indexed citations
17.
Onoue, Satomi, Shingen Misaka, Yohei Kawabata, & Shizuo Yamada. (2009). New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Expert Opinion on Drug Delivery. 6(8). 793–811. 21 indexed citations
18.
Misaka, Shingen, Yosuke Aoki, Shin-ichiro Karaki, et al.. (2009). Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: Anti-inflammatory effect in experimental asthmatic rats. Peptides. 31(1). 72–78. 28 indexed citations
19.
Misaka, Shingen, Shinya Uchida, Hiromitsu Imai, et al.. (2009). Pharmacokinetics and pharmacodynamics of low doses of midazolam administered intravenously and orally to healthy volunteers. Clinical and Experimental Pharmacology and Physiology. 37(3). 290–295. 17 indexed citations
20.
Onoue, Satomi, Shingen Misaka, & Shizuo Yamada. (2008). Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications. Naunyn-Schmiedeberg s Archives of Pharmacology. 377(4-6). 579–590. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hatem A. Salem Breakdown of academic impact, for papers by Tomomi Sugiyama Breakdown of academic impact, for papers by Emad H. M. Hassanein Breakdown of academic impact, for papers by Salma Malik Breakdown of academic impact, for papers by Amr A. Fouad Breakdown of academic impact, for papers by Sumit Sharma Breakdown of academic impact, for papers by Mona F. Schaalan Breakdown of academic impact, for papers by Sana Nafees Breakdown of academic impact, for papers by Eman Said Breakdown of academic impact, for papers by Wani Arjumand
Rankless by CCL
2026